Systemic thromboembolic adverse events in patients treated with intravitreal anti-VEGF drugs for neovascular age-related macular degeneration: An overview

导出原文传递

翻译打印收藏纠错

作者： Semeraro,F. ^[1] ; Morescalchi,F. ^[2] ; Duse,S. ; Gambicorti,E. ; Romano,M.R. ; Costagliola,C.

作者单位： University of Molise, Ophthalmology Clinic, Department of Health Science, Campobasso, Italy ^[1] University of Brescia, Spedali Civili di Brescia, Radiological Specialties and Public Health ^[2]

关键词 Aflibercept Age-related macular degeneration Anti-VEGF Bevacizumab Hypertension Myocardial infarction Pegaptanib Ranibizumab Side effects Stroke

发布时间 2014-09-25

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Expert opinion on drug safety

2014年13卷6期

785-802页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Systemic thromboembolic adverse events in patients treated with intravitreal anti-VEGF drugs for neovascular age-related macular degeneration: An overview

Expert opinion on drug safety

相似文献

Expert opinion on drug safety

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Systemic thromboembolic adverse events in patients treated with intravitreal anti-VEGF drugs for neovascular age-related macular degeneration: An overview

Expert opinion on drug safety

相似文献

Expert opinion on drug safety

相关期刊

检索历史清除